Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Radiograph
100%
Radiation Therapy Oncology Group
100%
Imaging Network
100%
American College of Radiology
100%
Regional Failure
100%
Definitive Chemoradiation Therapy
100%
Regional Lymph Nodes
100%
Lymph Node Uptake
100%
Standardized Uptake Value
88%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
77%
Primary Tumor
44%
Local-regional Control
33%
FDG-avid
22%
Cox Proportional Hazards Regression
11%
Non-associated
11%
Patient Outcomes
11%
Overall Survival
11%
Radiation Therapy
11%
Radiation Dose
11%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
11%
Statistical Analysis
11%
Kaplan-Meier Curve
11%
Regression Modeling
11%
Core Laboratory
11%
Wilcoxon Signed-rank Test
11%
Log-rank Test
11%
Boost Volume
11%
Residual Activity
11%
Absolute Value
11%
Value Measurement
11%
Concurrent Chemoradiation Therapy
11%
Event Time
11%
Data Value
11%
Core Network
11%
Residual Metabolic Activity
11%
Medicine and Dentistry
Chemoradiation Therapy
100%
Radiology
100%
Radiation Therapy
100%
Lymph Node
100%
Non Small Cell Lung Cancer
100%
Fluorodeoxyglucose F 18
100%
Oncology
100%
Positron Emission Tomography
88%
Standardized Uptake Value
88%
Fluorodeoxyglucose
77%
Primary Tumor
44%
Overall Survival
11%
Wilcoxon Signed Ranks Test
11%
Proportional Hazards Model
11%
Kaplan Meier Method
11%
Log Rank Test
11%
Earth and Planetary Sciences
Tomography
100%
Radiation Therapy
100%
Emissions
100%
Positron
100%
Pretreatment
37%
Rank Test
25%
Radiation Dose
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Non Small Cell Lung Cancer
100%
Fluorodeoxyglucose F 18
100%
Fluorodeoxyglucose
100%
Primary Tumor
57%
Overall Survival
14%
Neuroscience
Radiation Therapy
100%
Lymph Node
100%
Fluorine-18
100%
Positron Emission Tomography
88%
Agricultural and Biological Sciences
Americans
100%
Lymph Node
100%
Positron-Emission Tomography
88%
Pretreatment
33%